ACIU
AC Immune Ltd
NASDAQ: ACIU · HEALTHCARE · BIOTECHNOLOGY
$2.97
-1.33% today
Updated 2026-05-06
Market cap
$303.29M
P/E ratio
—
P/S ratio
84.88x
EPS (TTM)
$-0.84
Dividend yield
—
52W range
$2 – $4
Volume
0.3M
AC Immune Ltd (ACIU) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $12.75M | $30.30M | $79.93M | $156.10M | $132.01M | $196.56M | $299.25M | $238.74M | $261.44M | $185.94M | $182.81M | $230.91M |
| Cash & equivalents | $11.25M | $3.31M | $76.52M | $152.21M | $124.38M | $156.46M | $193.59M | $160.89M | $82.22M | $31.59M | $78.49M | $36.27M |
| Current assets | $11.96M | $29.67M | $79.35M | $154.89M | $129.53M | $192.93M | $292.77M | $231.77M | $202.63M | $128.09M | $125.15M | $171.99M |
| Total liabilities | $7.89M | $6.83M | $8.89M | $13.72M | $15.17M | $18.93M | $26.81M | $23.26M | $29.46M | $16.95M | $22.17M | $118.64M |
| Current liabilities | $7.89M | $4.42M | $6.10M | $9.92M | $9.75M | $13.08M | $17.51M | $14.02M | $20.03M | $11.48M | $13.58M | $100.84M |
| Long-term debt | — | $0.00 | $0.00 | $0.00 | $395000.00 | $186000.00 | $0.00 | — | — | — | — | — |
| Shareholder equity | $3.93M | $23.47M | $71.04M | $142.38M | $116.84M | $177.62M | $272.44M | $215.48M | $231.98M | $168.99M | $160.64M | $112.27M |
| Retained earnings | $-70.09M | $-60.45M | $-40.38M | $-46.92M | $-72.61M | $-121.88M | $-75.52M | $-132.85M | $-200.94M | $-264.01M | $-316.20M | $-368.24M |
| Accounts receivable | $169000.00 | $25.99M | $316000.00 | $1.41M | $3.72M | $4.10M | $1.40M | $1.59M | $975000.00 | $408000.00 | $15.05M | $1.10M |
| Inventory | — | $320000.00 | $2.46M | $389000.00 | $-1.36M | $0.00 | $-1.40M | $-1.92M | $-1.40M | $1.00 | $-622000.00 | — |
| Goodwill | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — |